{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:10:59Z","timestamp":1794647459589,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite the wide variety of Next Generation Sequencing (NGS)-based methods, it remains challenging to detect mutations present at very low frequencies. This problem is particularly relevant in oncology, where the limiting amount of input material, and its low quality, often limit the performance of the assays. Unique Molecular Identifiers (UMIs) are a molecular barcoding system often coupled with computational methods of noise suppression to improve the reliability of detection of rare variants. Although widely adopted, UMI inclusion imposes additional technical complexity and sequencing cost. Currently, there are no guidelines on UMI usage nor a comprehensive evaluation of their advantage across different applications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used DNA sequencing data generated by molecular barcoding and hybridization-based enrichment, from various types and quantities of input material (fresh frozen, formaldehyde-treated and cell-free DNA), to evaluate the performance of variant calling in different clinically relevant contexts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Noise suppression achieved by read grouping based on fragment mapping positions ensures reliable variant calling for many experimental designs even without exogenous UMIs. Exogenous barcodes significantly improve performance only when mapping position collisions occur, which is common in cell-free DNA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We demonstrate that UMI usage is not universally beneficial across experimental designs and that it is worthwhile to critically consider the comparative advantage of UMI usage for a given NGS application prior to experimental design.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04160-0","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T13:02:23Z","timestamp":1683291743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Benefits of applying molecular barcoding systems are not uniform across different genomic applications"],"prefix":"10.1186","volume":"21","author":[{"given":"Jonathan","family":"Bieler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slawomir","family":"Kubik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Macheret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pozzorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Willig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3484-9147","authenticated-orcid":false,"given":"Zhenyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"issue":"1","key":"4160_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41598-017-00520-1","volume":"7","author":"Y Shu","year":"2017","unstructured":"Shu Y, Wu X, Tong X, Wang X, Chang Z, Mao Y, et al. Circulating tumor DNA mutation profiling by targeted next generation sequencing provides guidance for personalized treatments in multiple cancer types. Sci Rep. 2017;7(1):583.","journal-title":"Sci Rep"},{"issue":"10","key":"4160_CR2","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1158\/1541-7786.MCR-16-0044","volume":"14","author":"S Volik","year":"2016","unstructured":"Volik S, Alcaide M, Morin RD, Collins C. Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies. Mol Cancer Res. 2016;14(10):898\u2013908.","journal-title":"Mol Cancer Res"},{"key":"4160_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007094","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014. https:\/\/doi.org\/10.1126\/scitranslmed.3007094.","journal-title":"Sci Transl Med"},{"issue":"8","key":"4160_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fcell.2020.00249","volume":"8","author":"JM Yoest","year":"2020","unstructured":"Yoest JM, Shirai CL, Duncavage EJ. Sequencing-based measurable residual disease testing in acute myeloid leukemia. Front Cell Dev Biol. 2020;8(8):249.","journal-title":"Front Cell Dev Biol"},{"issue":"23","key":"4160_CR5","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1182\/blood-2018-06-858613","volume":"132","author":"A Perrot","year":"2018","unstructured":"Perrot A, Lauwers-Cances V, Corre J, Robillard N, Hulin C, Chretien ML, et al. Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma. Blood. 2018;132(23):2456\u201364.","journal-title":"Blood"},{"issue":"1","key":"4160_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13059-019-1659-6","volume":"20","author":"X Ma","year":"2019","unstructured":"Ma X, Shao Y, Tian L, Flasch DA, Mulder HL, Edmonson MN, et al. Analysis of error profiles in deep next-generation sequencing data. Genome Biol. 2019;20(1):50.","journal-title":"Genome Biol"},{"issue":"36","key":"4160_CR7","doi-asserted-by":"publisher","first-page":"14508","DOI":"10.1073\/pnas.1208715109","volume":"109","author":"MW Schmitt","year":"2012","unstructured":"Schmitt MW, Kennedy SR, Salk JJ, Fox EJ, Hiatt JB, Loeb LA. Detection of ultra-rare mutations by next-generation sequencing. Proc Natl Acad Sci. 2012;109(36):14508\u201313.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"4160_CR8","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1038\/s41467-021-24109-5","volume":"12","author":"A Rose Brannon","year":"2021","unstructured":"Rose Brannon A, Jayakumaran G, Diosdado M, Patel J, Razumova A, Hu Y, et al. Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS. Nat Commun. 2021;12(1):3770.","journal-title":"Nat Commun"},{"issue":"1","key":"4160_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nmeth.1778","volume":"9","author":"T Kivioja","year":"2012","unstructured":"Kivioja T, V\u00e4h\u00e4rautio A, Karlsson K, Bonke M, Enge M, Linnarsson S, et al. Counting absolute numbers of molecules using unique molecular identifiers. Nat Methods. 2012;9(1):72\u20134.","journal-title":"Nat Methods"},{"issue":"1","key":"4160_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13059-020-01988-3","volume":"21","author":"K Mitchell","year":"2020","unstructured":"Mitchell K, Brito JJ, Mandric I, Wu Q, Knyazev S, Chang S, et al. Benchmarking of computational error-correction methods for next-generation sequencing data. Genome Biol. 2020;21(1):71.","journal-title":"Genome Biol"},{"issue":"3","key":"4160_CR11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gr.209601.116","volume":"27","author":"T Smith","year":"2017","unstructured":"Smith T, Heger A, Sudbery I. UMI-tools: modeling sequencing errors in unique molecular identifiers to improve quantification accuracy. Genome Res. 2017;27(3):491\u20139.","journal-title":"Genome Res"},{"key":"4160_CR12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1200\/CCI.21.00057","volume":"5","author":"J Bieler","year":"2021","unstructured":"Bieler J, Pozzorini C, Garcia J, Tuck AC, Macheret M, Willig A, et al. High-throughput nucleotide resolution predictions of assay limitations increase the reliability and concordance of clinical tests. JCO Clin Cancer Inform. 2021;5:1085\u201395.","journal-title":"JCO Clin Cancer Inform"},{"issue":"14","key":"4160_CR13","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"issue":"1","key":"4160_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1137\/141000671","volume":"59","author":"J Bezanson","year":"2017","unstructured":"Bezanson J, Edelman A, Karpinski S, Shah VB. Julia: a fresh approach to numerical computing. SIAM Rev. 2017;59(1):65\u201398.","journal-title":"SIAM Rev"},{"issue":"403","key":"4160_CR15","doi-asserted-by":"publisher","first-page":"eaan2415","DOI":"10.1126\/scitranslmed.aan2415","volume":"9","author":"J Phallen","year":"2017","unstructured":"Phallen J, Sausen M, Adleff V, Leal A, Hruban C, White J, et al. Direct detection of early-stage cancers using circulating tumor DNA. Sci Transl Med. 2017;9(403):eaan2415.","journal-title":"Sci Transl Med"},{"issue":"2","key":"4160_CR16","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1186\/gb-2011-12-2-r18","volume":"12","author":"D Aird","year":"2011","unstructured":"Aird D, Ross MG, Chen WS, Danielsson M, Fennell T, Russ C, et al. Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol. 2011;12(2):R18.","journal-title":"Genome Biol"},{"issue":"8","key":"4160_CR17","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.tig.2021.04.005","volume":"37","author":"DSC Han","year":"2021","unstructured":"Han DSC, Lo YMD. The nexus of cfDNA and nuclease biology. Trends Genet. 2021;37(8):758\u201370.","journal-title":"Trends Genet"},{"issue":"1\u20132","key":"4160_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","volume":"164","author":"MW Snyder","year":"2016","unstructured":"Snyder MW, Kircher M, Hill AJ, Daza RM, Shendure J. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell. 2016;164(1\u20132):57\u201368.","journal-title":"Cell"},{"issue":"12","key":"4160_CR19","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.3390\/cancers13123002","volume":"13","author":"KK Maass","year":"2021","unstructured":"Maass KK, Schad PS, Finster AME, Puranachot P, Rosing F, Wedig T, et al. From sampling to sequencing: a liquid biopsy pre-analytic workflow to maximize multi-layer genomic information from a single tube. Cancers. 2021;13(12):3002.","journal-title":"Cancers"},{"issue":"4","key":"4160_CR20","doi-asserted-by":"publisher","first-page":"e0211400","DOI":"10.1371\/journal.pone.0211400","volume":"14","author":"SJ McDonough","year":"2019","unstructured":"McDonough SJ, Bhagwate A, Sun Z, Wang C, Zschunke M, Gorman JA, et al. Use of FFPE-derived DNA in next generation sequencing: DNA extraction methods. PLOS ONE. 2019;14(4):e0211400.","journal-title":"PLOS ONE"},{"issue":"1","key":"4160_CR21","doi-asserted-by":"publisher","first-page":"14593","DOI":"10.1038\/s41598-020-71323-0","volume":"10","author":"K Saunders","year":"2020","unstructured":"Saunders K, Bert AG, Dredge BK, Toubia J, Gregory PA, Pillman KA, et al. Insufficiently complex unique-molecular identifiers (UMIs) distort small RNA sequencing. Sci Rep. 2020;10(1):14593.","journal-title":"Sci Rep"},{"issue":"13","key":"4160_CR22","doi-asserted-by":"publisher","first-page":"i202","DOI":"10.1093\/bioinformatics\/bty264","volume":"34","author":"K Clement","year":"2018","unstructured":"Clement K, Farouni R, Bauer DE, Pinello L. AmpUMI: design and analysis of unique molecular identifiers for deep amplicon sequencing. Bioinformatics. 2018;34(13):i202\u201310.","journal-title":"Bioinformatics"},{"issue":"1","key":"4160_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12864-019-5583-7","volume":"20","author":"J Chung","year":"2019","unstructured":"Chung J, Lee KW, Lee C, Shin SH, Kyung S, Jeon HJ, et al. Performance evaluation of commercial library construction kits for PCR-based targeted sequencing using a unique molecular identifier. BMC Genomics. 2019;20(1):216.","journal-title":"BMC Genomics"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04160-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04160-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04160-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T13:04:36Z","timestamp":1683291876000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04160-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4160"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04160-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are employees of SOPHiA GENETICS.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"305"}}